Oramed

Oramed Pharmaceuticals is a technological pioneer in the field of oral and vaccine oral delivery solutions, which are currently provided by injection. The company aims to create a revolution in the treatment of diabetes using the flagship product - oral insulin pill (ORMD-0801) given to diabetics patients.Ormed's diabetes treatment pill is distributed worldwide and approved by the FDA. These days, Oramed is developing a vaccine against the Covid-19 virus, which will not be will be taken directly by mouth and will contain fewer side effects Oramed was founded in 2006, based on research conducted over more than 30 years by researchers from Hadassah Medical Center in Jerusalem, and its offices are located in Jerusalem. Oramed is traded simultaneously on the Nasdaq and the Tel Aviv Stock Exchange